5.7 C
Glasgow
Thursday, January 15, 2026
spot_img

Ooops... Error 404

Sorry, but the page you are looking for doesn't exist.

Go to the homepage

Mercury Bio launches MB-TIP

biotech Jim Cornall -
Mercury Bio Inc. has launched MB-TIP (Mercury Bio - targeting intracellular pathologies) which harnesses proprietary exosome-based yEV technology to deliver large proteins, nanobodies, and...

Beginnings of breast cancer revealed

biotech Jim Cornall -
A study led by PhD student Sara Oster Flayshman under the guidance of Rami Aqeilan and Yotam Drier from the Faculty of Medicine at...

Reversal of metabolic dysfunction and liver fibrosis shown

biotech Jim Cornall -
Espervita Therapeutics has announced the publication in Cell Metabolism of what it calls 'groundbreaking preclinical data' demonstrating that its lead compound, EVT0185, a first-in-class...

Neuraxpharm enhances ADHD treatment options in Europe

biotech Jim Cornall -
Neuraxpharm Group has announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) prolonged-release tablets, two differentiated treatments designed...

Trenchant BioSystems shows reduction of CGT manufacturing times to 2.5 days

biotech Jim Cornall -
Trenchant BioSystems Inc., a CGT manufacturing platform developer for gene-modified cells, has announced multiple internal and independent external data readouts for the prototype of...

DISCO Pharmaceuticals enters licence agreement with Amgen on cancer

biotech Jim Cornall -
DISCO Pharmaceuticals has announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface...

Researchers uncover axonal protein synthesis defect in ALS

biotech Jim Cornall -
Researchers at VIB and KU Leuven in Belgium have identified a molecular process that allows motor neurons to maintain protein production, a process that...

Circio and University of Texas Medical Branch to evaluate circVec for treating infectious diseases

biotech Jim Cornall -
Circio Holding ASA, a biotechnology company developing novel circular RNA expression technology for gene and cell therapy, and The University of Texas Medical Branch...
- Advertisement -spot_img

Latest Articles

Load more

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media